Ming Wei

1.7k total citations
51 papers, 1.3k citations indexed

About

Ming Wei is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Ming Wei has authored 51 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Immunology. Recurrent topics in Ming Wei's work include Virus-based gene therapy research (10 papers), RNA Interference and Gene Delivery (7 papers) and Immunotherapy and Immune Responses (7 papers). Ming Wei is often cited by papers focused on Virus-based gene therapy research (10 papers), RNA Interference and Gene Delivery (7 papers) and Immunotherapy and Immune Responses (7 papers). Ming Wei collaborates with scholars based in France, United States and China. Ming Wei's co-authors include Efstathios Boviatsis, T Ooka, E. Antonio Chiocca, Maureen Chase, E. Antonio Chiocca, Takashi Tamiya, X. O. Breakefield, Neil W. Kowall, John S. Yu and R L Martuza and has published in prestigious journals such as Journal of Biological Chemistry, The EMBO Journal and PLoS ONE.

In The Last Decade

Ming Wei

50 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Wei France 19 574 574 541 313 196 51 1.3k
Cristina Balagué Spain 21 1.1k 1.9× 629 1.1× 852 1.6× 214 0.7× 136 0.7× 27 1.7k
Norma Bloy France 19 483 0.8× 776 1.4× 185 0.3× 841 2.7× 143 0.7× 39 1.5k
Rozanne Arulanandam Canada 17 623 1.1× 507 0.9× 342 0.6× 152 0.5× 46 0.2× 47 1.1k
John A. Feild United States 16 905 1.6× 405 0.7× 341 0.6× 181 0.6× 141 0.7× 24 1.5k
Ryan D. Chow United States 21 1.2k 2.1× 661 1.2× 266 0.5× 355 1.1× 120 0.6× 40 1.9k
Hitto Kaufmann Germany 14 1.2k 2.2× 160 0.3× 291 0.5× 135 0.4× 131 0.7× 25 1.6k
Natalia Lapteva United States 21 517 0.9× 1.1k 1.9× 288 0.5× 1.1k 3.5× 69 0.4× 45 1.7k
Hikaru Nagahara Japan 12 1.1k 1.9× 349 0.6× 244 0.5× 164 0.5× 116 0.6× 19 1.4k
Zhi Hong Lu United States 19 794 1.4× 339 0.6× 192 0.4× 227 0.7× 71 0.4× 44 1.3k
S L Woo United States 16 698 1.2× 265 0.5× 567 1.0× 182 0.6× 247 1.3× 23 1.4k

Countries citing papers authored by Ming Wei

Since Specialization
Citations

This map shows the geographic impact of Ming Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Wei more than expected).

Fields of papers citing papers by Ming Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Wei. The network helps show where Ming Wei may publish in the future.

Co-authorship network of co-authors of Ming Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Wei. A scholar is included among the top collaborators of Ming Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Wei. Ming Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wei, Ming, et al.. (2022). The efficiency of endoscopic versus open surgical interventions in adult benign laryngotracheal stenosis: a meta-analysis. European Archives of Oto-Rhino-Laryngology. 280(5). 2421–2433. 9 indexed citations
2.
Wei, Ming, Jingjing Zuo, Jibo Han, & Jinhui Chen. (2021). The impact of comorbid allergic airway disease on the severity and mortality of COVID-19: a systematic review and meta-analysis. European Archives of Oto-Rhino-Laryngology. 279(4). 1675–1690. 2 indexed citations
3.
Wei, Ming, Xinwei Wang, Bo Chen, et al.. (2019). Research Progress into the Function of Purple Acid Phosphatase Gene Family in Plants. Chinese Bulletin of Botany. 54(1). 93. 2 indexed citations
4.
Wei, Ming, et al.. (2016). Length of Menstrual Cycle and Risk of Endometriosis. Medicine. 95(9). e2922–e2922. 37 indexed citations
5.
Wei, Ming, et al.. (2016). Effects of Prenatal Environmental Exposures on the Development of Endometriosis in Female Offspring. Reproductive Sciences. 23(9). 1129–1138. 14 indexed citations
6.
Lhuillier, Claire, Clément Barjon, Toshiro Niki, et al.. (2015). Impact of Exogenous Galectin-9 on Human T Cells. Journal of Biological Chemistry. 290(27). 16797–16811. 50 indexed citations
7.
Collery, Philippe, Ahmed Mohsen, Anthony Kermagoret, et al.. (2015). Antitumor activity of a rhenium (I)-diselenoether complex in experimental models of human breast cancer. Investigational New Drugs. 33(4). 848–860. 50 indexed citations
8.
Villaverde, Marcela Solange, et al.. (2014). Suicide plus immune gene therapy prevents post-surgical local relapse and increases overall survival in an aggressive mouse melanoma setting. International Immunopharmacology. 22(1). 167–175. 9 indexed citations
9.
Barjon, Clément, Toshiro Niki, Benjamin Vérillaud, et al.. (2012). A novel monoclonal antibody for detection of galectin-9 in tissue sections: application to human tissues infected by oncogenic viruses. Infectious Agents and Cancer. 7(1). 16–16. 14 indexed citations
10.
Gressette, Mélanie, et al.. (2011). Rapid obtention of stable, bioluminescent tumor cell lines using a tCD2-luciferase chimeric construct. BMC Biotechnology. 11(1). 26–26. 1 indexed citations
11.
Trojan, Jerzy, Ming Wei, Piotr Kopiński, et al.. (2010). Antisense anti IGF-I cellular therapy of malignant tumours: Immune response in cancer patients. Biomedicine & Pharmacotherapy. 64(8). 576–578. 7 indexed citations
12.
13.
Kopiński, Piotr, Ming Wei, Aleksandra Głogowska, et al.. (2002). IGF-I: from diagnostic to triple-helix gene therapy of solid tumors.. Acta Biochimica Polonica. 49(4). 979–990. 13 indexed citations
14.
Wei, Ming, et al.. (1998). Effects on brain tumor cell proliferation by an adenovirus vector that bears the Interleukin-4 gene. Journal of NeuroVirology. 4(2). 237–241. 12 indexed citations
15.
Tanner, Jerome E., Ming Wei, Caroline Alfieri, et al.. (1997). Antibody and Antibody-Dependent Cellular Cytotoxicity Responses against the BamHI A Rightward Open-Reading Frame-1 Protein of Epstein-Barr Virus (EBV) in EBV-Associated Disorders. The Journal of Infectious Diseases. 175(1). 38–46. 34 indexed citations
16.
Ono, Yasuhiro, Keiro Ikeda, Ming Wei, et al.. (1997). Regression of Experimental Brain Tumors with 6-Thioxanthine and Escherichia coli gpt Gene Therapy. Human Gene Therapy. 8(17). 2043–2055. 16 indexed citations
17.
Bashir, Rifaat, Fred H. Hochberg, & Ming Wei. (1995). Epstein-Barr virus and brain lymphomas. Journal of Neuro-Oncology. 24(2). 195–205. 4 indexed citations
18.
Wei, Ming, Takashi Tamiya, Robert Hurford, et al.. (1995). Enhancement of Interleukin-4-Mediated Tumor Regression in Athymic Mice by In Situ Retroviral Gene Transfer. Human Gene Therapy. 6(4). 437–443. 53 indexed citations
19.
Wei, Ming, Takashi Tamiya, Maureen Chase, et al.. (1994). Experimental Tumor Therapy in Mice Using the Cyclophosphamide-Activating Cytochrome P450 2B1 Gene. Human Gene Therapy. 5(8). 969–978. 123 indexed citations
20.
Boviatsis, Efstathios, Maureen Chase, Ming Wei, et al.. (1994). Gene Transfer into Experimental Brain Tumors Mediated by Adenovirus, Herpes Simplex Virus, and Retrovirus Vectors. Human Gene Therapy. 5(2). 183–191. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cristina Balagué Breakdown of academic impact, for papers by Norma Bloy Breakdown of academic impact, for papers by Rozanne Arulanandam Breakdown of academic impact, for papers by John A. Feild Breakdown of academic impact, for papers by Ryan D. Chow Breakdown of academic impact, for papers by Hitto Kaufmann Breakdown of academic impact, for papers by Natalia Lapteva Breakdown of academic impact, for papers by Hikaru Nagahara Breakdown of academic impact, for papers by Zhi Hong Lu Breakdown of academic impact, for papers by S L Woo
Rankless by CCL
2026